Načítá se...
Clinical and Regulatory Concerns of Biosimilars: A Review of Literature
Although biosimilars have been part of clinical practice for more than a decade, healthcare professionals (HCPs) do not fully accept them. This is because of the perception that biosimilars may not be like their originators in terms of quality, safety, and efficacy. This study aims to evaluate the c...
Uloženo v:
| Vydáno v: | Int J Environ Res Public Health |
|---|---|
| Hlavní autoři: | , , , , , |
| Médium: | Artigo |
| Jazyk: | Inglês |
| Vydáno: |
MDPI
2020
|
| Témata: | |
| On-line přístup: | https://ncbi.nlm.nih.gov/pmc/articles/PMC7460311/ https://ncbi.nlm.nih.gov/pubmed/32796549 https://ncbi.nlm.nih.govhttp://dx.doi.org/10.3390/ijerph17165800 |
| Tagy: |
Přidat tag
Žádné tagy, Buďte první, kdo otaguje tento záznam!
|